7 Analysts Have This to Say About Repligen
Portfolio Pulse from Benzinga Insights
Repligen (NASDAQ:RGEN) has received 7 analyst ratings in the last quarter, with 1 being bullish and 6 somewhat bullish. The average 12-month price target for the company is $191.71, which has increased by 3.07% over the past month.
October 17, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Repligen has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up.
Analyst ratings often influence investor sentiment. In this case, the majority of the ratings are bullish, which indicates a positive outlook for the company. This could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100